Evaluation Model Used: gpt-5
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Epoch: 5.0
	Rank: 32
	QLoRA Alpha: 48.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is a better measure of undernutrition than birth weight percentiles. This study suggests that BF% should be used in conjunction with birth weight percentiles as a measure of undernutrition in neonates. Neonatal morbidity is associated with both low BF% and low birth weight percentiles, but BF% is a more sensitive measure of undernutrition. Further research is needed to determine the optimal cut-off point for BF% to define undernutrition in neonates. BF% should be used to identify neonates at risk of undernutrition and to guide nutritional interventions.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.8
Reasoning:
The response correctly conveys that body fat percentage (BF%) is more strongly associated with neonatal morbidity than birth weight percentiles, aligning with the study’s finding that BF% better identifies undernourished neonates at risk. It also notes that both measures are associated with morbidity. However, it overreaches slightly by labeling BF% as “more sensitive” without direct evidence of sensitivity metrics, and it omits the nuance that BF% can identify appropriately grown yet undernourished neonates and exclude small neonates not at risk.

conciseness: 0.7
Reasoning:
The response directly answers the question upfront by stating that low BF% is a better measure, which is concise and on point. However, it adds several extra sentences (e.g., suggesting combined use, need for further research, and guidance on interventions) that are not necessary for a concise answer to the specific question, reducing overall conciseness.

relevance: 0.6
Reasoning:
The response is broadly relevant: it answers “yes” and aligns with the context that BF% is more closely associated with neonatal morbidity than birth weight percentiles. However, it does not provide or cite a direct quote from the context, nor does it reference specific data (e.g., the higher OR for BF% vs birth weight percentiles). It also adds recommendations (use in conjunction, need for further research) that are not explicitly supported by the provided text. Overall, relevant but lacking a real quote and precise anchoring to the context.

coherence: 0.9
Reasoning:
The response directly answers the question with a clear stance and provides a brief, logically ordered rationale. It stays focused on the comparison, notes both measures’ association with morbidity, and adds practical implications. While slightly repetitive and mixing “better” with “use in conjunction,” it remains coherent and well-structured.

helpfulness: 0.8
Reasoning:
The response correctly answers that low BF% is a better measure of undernutrition than birth weight percentiles and notes that both are associated with morbidity, aligning with the study’s finding of a stronger association for BF%. It is generally helpful and appropriate. However, it omits the key nuance that BF% can identify appropriately grown but undernourished neonates and exclude small neonates not at risk, which is central to the ground truth. Some added suggestions (e.g., using BF% to guide interventions, need for cut-offs) are reasonable but not directly supported by the provided summary.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: Our results show that the limb salvage rate is high (90%) and that the mean time to heal the lesion is longer than 190 days. This suggests that the treatment of ischemic Charcot foot should be different from the treatment of other types of neuroarthropathies. This is probably due to the fact that ischemic Charcot foot is a specific type of neuroarthropathy with a higher risk of infection and a greater need for orthopedic correction. The longer healing time could be related to the severity of the disease and the need for a more complex surgical approach. Further studies are needed to confirm these results.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.4
Reasoning:
The answer correctly reports the limb salvage rate and approximate healing time from the provided data, but it fails to address the key conclusion: that revascularization is necessary to support surgical and orthopedic management in ischemic Charcot foot, enabling limb salvage and avoiding major amputation. It also introduces speculative reasoning (e.g., higher infection risk, greater need for orthopedic correction) not supported by the given context. Overall, it is only partially responsive to the question about whether treatment differs and why.

conciseness: 0.4
Reasoning:
The response includes key study outcomes (90% limb salvage and ~197-day healing) but does not directly and concisely answer the question. It adds speculative explanations (infection risk, complexity) and omits the core, succinct takeaway that revascularization is necessary to support surgical/orthopedic treatment for limb salvage. Overall, it’s wordier than needed and not pointed.

relevance: 0.6
Reasoning:
The response is partially relevant: it uses correct figures from the context (90% limb salvage; ~197 days to heal) and answers the question by implying a different treatment approach. However, it does not reference or quote the key contextual point that revascularization is necessary to support surgical and orthopedic treatment to avoid amputation. It also introduces unsupported speculation (e.g., higher infection risk as a general feature). No direct quote from the context is provided.

coherence: 0.8
Reasoning:
The response is coherent and stays focused on the question. It references the study’s key outcomes (90% limb salvage, ~197-day healing time) and uses them to argue that ischemic Charcot foot warrants a different treatment approach. The reasoning is logically structured and flows from results to implications. However, it remains somewhat vague about what “different treatment” entails and relies on speculative language without detailing specific modalities (e.g., revascularization) that differentiate management.

helpfulness: 0.5
Reasoning:
The response restates key outcomes (90% limb salvage, prolonged healing time) and suggests that ischemic Charcot foot may require a different treatment approach, which aligns partially with the study’s implications. However, it fails to explicitly highlight the central conclusion that revascularization is necessary to support surgical and orthopedic management to avoid major amputation and achieve limb/foot salvage. It also introduces speculative explanations (higher infection risk, greater need for orthopedic correction) not grounded in the provided context.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Radical hysterectomy for endometrial adenocarcinoma with suspected gross cervical involvement was not shown to be effective in this study. The GOTIC-005 study found that the type of surgical procedure did not affect the prognosis of patients with endometrial adenocarcinoma. Patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions had similar prognosis regardless of the type of hysterectomy performed. Therefore, radical hysterectomy can be omitted for patients with endometrial adenocarcinoma with suspected gross cervical involvement. However, the decision to perform radical hysterectomy should be carefully considered in each patient, considering the clinical stage, the presence of cervical involvement, and the patient's individual preferences and prognosis. Prolonged operative time and higher rates of blood transfusion and severe urinary tract dysfunction were observed in patients who underwent radical hysterectomy. Therefore, these patients should be closely monitored for potential complications.
Endometrial adenocarcinoma with suspected gross cervical involvement is a challenging disease to treat. Although radical hysterectomy is recommended for patients with endometrial adenocarcinoma with suspected gross cervical involvement, the efficacy of this procedure has not been confirmed. In this study, the GOTIC-005 trial, the prognosis of patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy was not affected by the type of surgical procedure performed. Therefore, radical hysterectomy can be omitted for patients with endometrial adenocarcinoma with suspected gross cervical involvement. However, the decision to perform radical hysterectomy should be carefully considered in each patient, considering the clinical stage, the presence of cervical involvement, and the patient's individual preferences and prognosis. Further studies are needed to determine the optimal treatment strategy for patients with endometrial adenocarcinoma with suspected gross cervical involvement.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.9
Reasoning:
The assistant’s answer accurately reflects the study’s findings: the type of hysterectomy was not an independent prognostic factor for survival outcomes, and radical hysterectomy was associated with longer operative time and more complications (e.g., transfusions, urinary dysfunction). It correctly concludes there was no survival benefit from radical hysterectomy and notes the need for individualized decisions and further studies. The statement that RH “can be omitted” is a reasonable inference but slightly stronger than the study’s cautious recommendation for prospective evaluation. Overall, the response is factually aligned with the ground truth.

conciseness: 0.5
Reasoning:
The response conveys the key points: no prognostic or survival advantage by hysterectomy type and higher morbidity with radical hysterectomy. However, it is repetitive, includes general advisories (e.g., close monitoring, patient preferences) that do not add concise value, and could be condensed into a brief summary. Thus, while accurate, it is not concise.

relevance: 0.9
Reasoning:
The response is highly relevant and accurately reflects the study’s findings from the provided context. It states that radical hysterectomy did not improve prognosis, that the type of hysterectomy was not an independent prognostic factor for survival, and that radical hysterectomy was associated with more adverse events (longer operative time, higher transfusion rates, severe urinary dysfunction). It also appropriately notes that further studies are needed. While slightly repetitive and not quoting verbatim, it faithfully uses the key points from the context to answer the question.

coherence: 0.8
Reasoning:
The response directly addresses the question, clearly stating that radical hysterectomy was not shown to improve prognosis and noting higher complication rates, aligning with the study’s findings. It is generally well-structured and coherent, with logical flow and appropriate qualifiers. However, it is repetitive, restating the same conclusions across two similar paragraphs, which slightly detracts from its organization and conciseness.

helpfulness: 0.8
Reasoning:
The response accurately reflects the study’s key findings: no survival benefit from radical hysterectomy (RH), type of hysterectomy not a prognostic factor, and higher perioperative/late complications with RH. It also appropriately notes the need for further studies and individualized decision-making. However, it is repetitive, somewhat overstates the conclusion by saying RH “can be omitted” without emphasizing the retrospective design, and loosely refers to the analysis as a “trial.” Overall, it is helpful and aligned with the ground truth but could be more concise and precise.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD are not uncommon and are associated with significant morbidity and cost. The presenting symptoms of readmissions are different from those of primary PDs and are associated with prolonged initial hospital stays. Intra-abdominal abscesses and pancreatic fistulas are the most common reasons for readmission. Future studies should focus on early and effective intervention strategies to prevent readmissions. These strategies should include the development of pancreatic fistula and intra-abdominal abscess prediction models, the identification of high-risk patients, and the optimization of perioperative care. Our data suggest that these strategies will require a multidisciplinary approach, including surgeons, gastroenterologists, and intensivists. These strategies may also require additional resources and infrastructure to improve patient care and reduce health-care costs. We propose that the development of a dedicated readmission program could be an effective strategy to prevent readmissions and improve patient outcomes. This program should be designed to address the needs of patients who are at risk of readmission and to provide the necessary support to these patients and their families. The success of such a program will depend on the ability to identify high-risk patients, to provide early intervention, and to optimize perioperative care. In addition, the development of readmission programs should be accompanied by the development of clinical pathways and guidelines that will guide the management of readmissions. These pathways should be developed with the input of surgeons, gastroenterologists, and other health-care professionals and should be based on the best available evidence. Finally, we suggest that readmission programs should be designed to address the needs of patients who are at risk of readmission and to provide the necessary support to these patients and their families. These programs should be designed to be flexible and adaptable to the needs of different hospitals and health-care systems. The development of readmission programs will require a multidisciplinary approach and will need to be accompanied by the development of clinical pathways and guidelines. These pathways will need to be based on the best available evidence and will need to be flexible and adaptable to the needs of different hospitals and health-care systems.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.4
Reasoning:
The assistant’s answer is generic and misses key findings from the provided study. It does not identify the independent predictors found (complexity/multivisceral resection and pancreatic fistula), omits ICU admission and prolonged initial stay as independent factors, and fails to emphasize that half of readmissions occur within 7 days and that prevention efforts should focus on early readmissions. It also introduces speculative programmatic suggestions not grounded in the study’s specific results and asserts that intra-abdominal abscesses and pancreatic fistulas are the most common reasons without support here. Overall, it only partially aligns with the ground truth.

conciseness: 0.2
Reasoning:
The response is verbose and repetitive, offering broad, speculative programmatic suggestions rather than concisely highlighting the key findings. It does not directly emphasize the key independent predictors (complex resection and pancreatic fistula) or the need to focus on preventing early readmissions, which constitute half of all readmissions. Overall, it lacks a succinct, targeted answer aligned with the study’s core conclusions.

relevance: 0.3
Reasoning:
The response is partially relevant but largely generic and not well anchored to the provided context. It does not cite or paraphrase the key findings from the text: that pancreatic fistula and complexity of initial resection (multivisceral resection), along with longer initial stay and ICU admission, were independently associated with readmissions, and that half of readmissions occur within 7 days, suggesting prevention should focus on early readmissions. It introduces unsupported statements (e.g., abscesses as most common reasons) and lacks direct reference to the specific, quoted results from the context.

coherence: 0.5
Reasoning:
The response is generally readable and stays on the topic of preventing readmissions after PD, offering high-level strategies. However, it is repetitive, generic, and not well-focused. It does not clearly synthesize the key predictive factors from the context (e.g., pancreatic fistula, multivisceral resection) or emphasize the importance of preventing early readmissions, which constitute half of all cases. The structure suffers from redundancy and lacks a concise, organized linkage between findings and targeted prevention measures.

helpfulness: 0.4
Reasoning:
The response is generic and only partially aligned with the study’s findings. It does not highlight the key independent predictors of readmission (pancreatic fistula and complexity/multivisceral resection) and omits the crucial point that half of readmissions occur within 7 days, suggesting a focus on preventing early readmissions. It also potentially mischaracterizes the most common causes of readmission and does not leverage the early vs late readmission differences reported. While it proposes broad strategies (risk stratification, multidisciplinary care), it lacks specificity to the study’s results.

================================================================================
Average correctness Score: 0.51
Average conciseness Score: 0.34
Average relevance Score: 0.51
Average coherence Score: 0.575
Average helpfulness Score: 0.49
